The global Live Cell Imaging Market, valued at US$2.88 billion in 2024, is forecasted to grow at a robust CAGR of 8.68%, reaching US$3.13 billion ...

The global Live Cell Imaging Market, valued at US$2.88 billion in 2024, is forecasted to grow at a robust CAGR of 8.68%, ...

The global Environmental Testing Products Market, valued at US$3.41 billion in 2023, is forecasted to grow at a robust CAGR of 7.1%, reaching ...

The global Environmental Testing Products Market, valued at US$3.41 billion in 2023, is forecasted to grow at a robust CAGR ...

Agilent Technologies Inc. announced today its participation at the American Association for Cancer Research (AACR) Annual Meeting on April 25-30, 2025 in Chicago, Illinois. Innovative Agilent products ...

In January 2023, Agilent Technologies recently acquired Avida Biomed, a startup life science company that develops high-performance target-enrichment techniques with unique capabilities for clinical ...

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...

In the wake of the stock market’s selloff, 125 of the 855 US-listed stocks Morningstar covers now sit at 5 stars, signaling ...

European certification for PD-L1 IHC 22C3 pharmDx to help gastric or GEJ adenocarcinoma patients for KEYTRUDA® therapy SANTA ...

The PD-L1 IHC 22C3 PharmDx (Code SK006) assay is now certified for use to aid treatment decisions for patients with gastric or gastroesophageal junction adenocarcinoma.